Product information

From Health Canada

No match found

No other product was found with the same active ingredient group.

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Approved

Current status date:

2024-08-22

Product name:

CLOROTEKAL

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02551063

Product Monograph/Veterinary Labelling:

Date: 2024-08-22 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

B. BRAUN MELSUNGEN AG
Carl-Braun-Str. 1
Melsungen
Hessen
Germany 34212

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intrathecal

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

72:00.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

N01BA04 CHLOROPROCAINE

Active ingredient group (AIG) number:See footnote5

0115360003

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
CHLOROPROCAINE HYDROCHLORIDE 10 MG / ML

Risk Management Plans See footnote 7

A Risk Management Plan (RMP) for this product was submitted.

Version 4.0.3

"Page details"

Date modified: